Subscribe to RSS
Transition and Evolution in Homeopathy Research
At the time of writing, the coronavirus disease 2019 (COVID-19) pandemic retains the status of a Public Health Emergency of International Concern, though some countries have begun transitioning their position to one of endemic disease. Many academic journals, including ours, have witnessed a burst of research activity related to the virus, with 25% of our last 10 issues' papers or correspondence being COVID-related (26 out of 103 items in total). All these 26 items are also presented together online in our Virtual Issue, Homeopathy and COVID-19 : five contributions in this February 2023 edition of the journal will be copied into that Virtual Issue.
As coronavirus and its effects have evolved, so too has the related research in homeopathy, as seen in four of the Original Research articles in this current issue. A study from Brazil compares the homeopathic treatment used for symptomatic cases of COVID-19 in March–April 2021 with cases treated in the corresponding 2 months of 2020: distinctly different disease characteristics, and thus the indicated homeopathic medicines, are apparent at the two stages of the pandemic. In another observational study – this time from the Directorate of AYUSH in Delhi – some new prominent COVID-19 symptoms are found during India's second major wave of coronavirus, indicating the use of additional homeopathic medicines. With a different research emphasis, a further study from the AYUSH group combines information available in ongoing international data collection projects to prepare a novel mini-repertory and corresponding app, giving indications for specific medicines for common COVID-19 symptoms. A fourth paper using observational methods reports an investigation of the “genus epidemicus” concept during the first wave of the pandemic in a small sample of patients in China: there are at least two distinct homeopathic symptom pictures, challenging the notion of a single “genus epidemicus” for COVID-19 in that population. Meanwhile, in Italy, a single practitioner recounts the consistent effectiveness of Eupatorium perfoliatum observed in the homeopathic management of non-serious cases of coronavirus.
Submissions of non-COVID research articles in homeopathy have continued almost as normal in the past 3 years, and elsewhere in this issue there are two in vitro studies in cell biology  plus a Commentary article that elucidates the miasm theory in homeopathy. Our current issue is completed by a Conference Report from the Homeopathy Research Institute about its one-day online conference held in 2022 which mitigated the loss of that organisation's biennial live three-day event that could not happen in 2021 due to continuing COVID-related travel restraints. During 2023 we shall begin to see the extent to which the homeopathy research community's activity evolves further as it transitions out of the acute pandemic.
Article published online:
23 January 2023
© 2023. Faculty of Homeopathy. This article is published by Thieme.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 World Health Organization. Statement on the thirteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. Published October 18, 2022, at: www.who.int/news/item/18-10-2022-statement-on-the-thirteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic
- 2 Editorial – The Lancet Infectious Diseases. Transitioning to endemicity with COVID-19 research. Lancet Infect Dis 2022; 22: 297
- 3 Virtual Issue: Homeopathy and COVID-19. www.thieme-connect.com/products/ejournals/issue/10.1055/s-010-49410
- 4 Fujino FMSC, Olandim AACC, Coggan JA. et al. Homeopathic treatment in patients with COVID-19: analysis of clinical evolution and comparison between cases in 2020 and 2021. Homeopathy 2023; 112: 3-11
- 5 Manchanda RK, Miglani A, Chakraborty M. et al. Homeopathic medicines in second wave of COVID-19: prognostic factor research. Homeopathy 2023; 112: 12-21
- 6 Miglani A, Manchanda RK, Kalsi A. et al. Test of a homeopathic algorithm for COVID-19: the importance of a broad perspective. Homeopathy 2023; 112: 22-29
- 7 Tournier A, Fok Y, van Haselen R, To A. Searching for the genus epidemicus in Chinese patients: findings from the Clificol COVID-19 Clinical Case Registry. Homeopathy 2023; 112: 30-39
- 8 Tomassone D. Homeopathic Eupatorium perfoliatum in the treatment of COVID-19. Homeopathy 2023; 112: 70-72
- 9 Valle ACV, Brunel HSS, Dallago BSL. et al. In-vitro growth kinetics of mesenchymal stem cells in cytotoxicity tests using low-diluted Viscum album . Homeopathy 2023; 112: 40-49
- 10 Joubert KS, George BP, Razlog R, Abrahamse H. The in-vitro effect of homeopathically prepared Rubus idaeus and 680 nm laser irradiation on cervical cancer cells. Homeopathy 2023; 112: 50-56
- 11 Vithoulkas G, Chabanov D. The evolution of miasm theory and its relevance to homeopathic prescribing. Homeopathy 2023; 112: 57-64
- 12 Roberts ER, Eizayaga JE, van der Werf ET, Tournier AL. HRI Online 2022: Leading international experts illustrate the positive impact of increased collaboration in homeopathy research. Homeopathy 2023; 112: 65-69